A phase III trial comparing UFT+PSK [tegafur/uracil + polysaccharide K] to UFT+LV [folinic acid] in stage IIB, III colorectal cancer
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Aug 2015
At a glance
- Drugs Polysaccharide K (Primary) ; Tegafur/uracil (Primary) ; Folinic acid
- Indications Colorectal cancer
- Focus Therapeutic Use
- 07 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 26 Feb 2009 Planned end date changed from 1 Apr 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov.
- 17 Dec 2006 New trial record.